Frederikssund, Denmark

Jacob Aas Hoellund-Jensen

This inventor holds 1 USPTO granted patent. Top assignee: Egalet Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacob Aas Hoellund-Jensen. Retrieved from https://idiyas.com/inventor/jacob-aas-hoellund-jensen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jacob Aas Hoellund-Jensen: Innovator in Pharmaceutical Compositions

Introduction

Jacob Aas Hoellund-Jensen is a notable inventor based in Frederikssund, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that are resistant to abuse. His innovative work aims to enhance the safety and efficacy of oral medications.

Latest Patents

Jacob holds a patent for "Pharmaceutical compositions resistant to abuse." This invention provides immediate release pharmaceutical compositions for oral administration that are designed to be resistant to misuse. His work in this area addresses a critical need in the pharmaceutical industry, focusing on patient safety and responsible medication use.

Career Highlights

Jacob is currently associated with Egalet Ltd., a company known for its commitment to developing innovative pharmaceutical solutions. His role at Egalet Ltd. allows him to contribute to groundbreaking research and development in the field of drug formulation.

Collaborations

Jacob has collaborated with esteemed colleagues, including Peter Holm Tygesen and Martin Rex Olsen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jacob Aas Hoellund-Jensen is a dedicated inventor whose work in pharmaceutical compositions is making a significant impact on the industry. His commitment to creating safer medications reflects his passion for improving patient care and advancing pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…